Ovarian Cancer Outcomes Improve with Fasting During Chemotherapy.
- In the news
Fasting around chemotherapy improves outcomes in advanced ovarian cancer patients, reducing insulin levels and enhancing treatment success.
- Why it matters: Understanding how dietary interventions influence cancer treatment can lead to better patient outcomes and potentially improve survival rates in ovarian cancer.
- What they did: The study involved patients with advanced ovarian cancer who fasted before and after chemotherapy, comparing their insulin levels and treatment results to those who ate normally.
- The result: Fasting was associated with lower insulin levels and better clinical outcomes, suggesting that dietary strategies like fasting could be a valuable adjunct to chemotherapy.